Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage

Oncogene volume 28, pages 3775–3786 (2009)Cite this article

Abstract

Proteasome inhibitors (PIs) are promising new therapeutic agents for treating non-small cell lung carcinoma (NSCLC). To investigate the mechanisms of action of PIs, we analyzed the proapoptotic activities of PIs (MG132 or Bortezomib) in NSCLC cells. We found that both MG132 (>1 μM) and Bortezomib (>0.025 μM) induced a significant apoptosis in NCI-H1703, a PI-sensitive NSCLC cell line, through initially activating the intrinsic apoptosis pathway, leading to the activation of a positive feedback mechanism (PFM), which then conveyed apoptosis signaling from the intrinsic pathway to the extrinsic pathway with formation of a signaling loop for maximal caspase activation. Mcl-1 and Noxa were identified to be the major anti-apoptotic and proapoptotic proteins, respectively, in PI-induced apoptosis and mutually exclusive in protein stability. Although the Mcl-1 protein was upregulated by proteasome inhibition, it was also subjected to caspase 3-dependent cleavage governed by the PFM. Moreover, it was revealed that Mcl-1 protein cleavage contributed to PFM-governed apoptosis in following inter-related ways: reducing the anti-apoptotic Mcl-1; generating the truncated proapoptotic Mcl-1S; and inducing a shift of balance between Mcl-1 and Noxa. It was further manifested that tumor necrosis factor-related apoptosis-inducing ligand boosted MG132's proapoptotic activity through strengthening the PFM in both NCI-H1703 and NCI-H358, a PI-resistant NSCLC cell line. Therefore, this study provides a basis for enhancing the efficacy of PIs in treating NSCLC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Adams J . (2004). The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5: 417–421.

    Article  CAS  Google Scholar 

  • Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA et al. (2006). Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9: 351–365.

    Article  CAS  Google Scholar 

  • Cregan SP, Dawson VL, Slack RS . (2004). Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785–2796.

    Article  CAS  Google Scholar 

  • Cryns V, Yuan J . (1998). Proteases to die for. Genes Dev 12: 1551–1570.

    Article  CAS  Google Scholar 

  • Cuconati A, Mukherjee C, Perez D, White E . (2003). DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev 17: 2922–2932.

    Article  CAS  Google Scholar 

  • Das T, Sa G, Sinha P, Ray PK . (1999). Induction of cell proliferation and apoptosis: dependence on the dose of the inducer. Biochem Biophys Res Commun 260: 105–110.

    Article  CAS  Google Scholar 

  • Davies AM, Lara Jr PN, Mack PC, Gandara DR . (2007). Incorporating bortezomib into the treatment of lung cancer. Clin Cancer Res 13: s4647–s4651.

    Article  Google Scholar 

  • Fiskum G, Craig SW, Decker GL, Lehninger AL . (1980). The cytoskeleton of digitonin-treated rat hepatocytes. Proc Natl Acad Sci USA 77: 3430–3434.

    Article  CAS  Google Scholar 

  • Green DR . (2006). At the gates of death. Cancer Cell 9: 328–330.

    Article  CAS  Google Scholar 

  • Hacker G . (2000). The morphology of apoptosis. Cell Tissue Res 301: 5–17.

    Article  CAS  Google Scholar 

  • Hassan M, Alaoui A, Feyen O, Mirmohammadsadegh A, Essmann F, Tannapfel A et al. (2008). The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways. Oncogene 27: 4557–4568.

    Article  CAS  Google Scholar 

  • Henderson CJ, Aleo E, Fontanini A, Maestro R, Paroni G, Brancolini C . (2005). Caspase activation and apoptosis in response to proteasome inhibitors. Cell Death Differ 12: 1240–1254.

    Article  CAS  Google Scholar 

  • Hunter AM, LaCasse EC, Korneluk RG . (2007). The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543–1568.

    Article  CAS  Google Scholar 

  • Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55: 10–30.

    Article  Google Scholar 

  • Jing N, Tweardy DJ . (2005). Targeting Stat3 in cancer therapy. Anticancer Drugs 16: 601–607.

    Article  CAS  Google Scholar 

  • Kruyt FA . (2008). TRAIL and cancer therapy. Cancer Lett 263: 14–25.

    Article  CAS  Google Scholar 

  • Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ . (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183–192.

    Article  CAS  Google Scholar 

  • Liu X, Yue P, Schonthal AH, Khuri FR, Sun SY . (2006). Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells. Cancer Res 66: 11115–11119.

    Article  CAS  Google Scholar 

  • MacFarlane M, Merrison W, Bratton SB, Cohen GM . (2002). Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 277: 36611–36616.

    Article  CAS  Google Scholar 

  • Milhas D, Cuvillier O, Therville N, Clave P, Thomsen M, Levade T et al. (2005). Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 280: 19836–19842.

    Article  CAS  Google Scholar 

  • Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA . (2008). Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584–594.

    Article  Google Scholar 

  • Muzio M, Chinnaiyan AM, Kischkel FC, O’Rourke K, Shevchenko A, Ni J et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827.

    Article  CAS  Google Scholar 

  • Nagy K, Szekely-Szuts K, Izeradjene K, Douglas L, Tillman M, Barti-Juhasz H et al. (2006). Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria. Pathol Oncol Res 12: 133–142.

    Article  CAS  Google Scholar 

  • Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM . (1998). DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858–5868.

    Article  CAS  Google Scholar 

  • Saulle E, Petronelli A, Pasquini L, Petrucci E, Mariani G, Biffoni M et al. (2007). Proteasome inhibitors sensitize ovarian cancer cells to TRAIL-induced apoptosis. Apoptosis 12: 635–655.

    Article  CAS  Google Scholar 

  • Steenland K . (1996). Epidemiology of occupation and coronary heart disease: research agenda. Am J Ind Med 30: 495–499.

    Article  CAS  Google Scholar 

  • Strasser A . (2005). The role of BH3-only proteins in the immune system. Nat Rev Immunol 5: 189–200.

    Article  CAS  Google Scholar 

  • Voortman J, Checinska A, Giaccone G, Rodriguez JA, Kruyt FA . (2007). Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCI-H460. Mol Cancer Ther 6: 1046–1053.

    Article  CAS  Google Scholar 

  • Wang S, El-Deiry WS . (2003). TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22: 8628–8633.

    Article  CAS  Google Scholar 

  • Weng C, Li Y, Xu D, Shi Y, Tang H . (2005). Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem 280: 10491–10500.

    Article  CAS  Google Scholar 

  • Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. (2005). Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294–1305.

    Article  CAS  Google Scholar 

  • Yuan B-Z, Chapman JA, Reynolds SH . (2008). Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cells. Transl Oncol 1: 129–140.

    Article  Google Scholar 

  • Yuan BZ, Jefferson AM, Millecchia L, Popescu NC, Reynolds SH . (2007). Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells. Exp Cell Res 313: 3868–3880.

    Article  CAS  Google Scholar 

  • Zhang HG, Wang J, Yang X, Hsu HC, Mountz JD . (2004). Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23: 2009–2015.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Robert Lanciotti (National Institute for Occupational Safety and Health) for his assistance with the flow cytometry assay.

Author information

Authors and Affiliations

  1. Laboratory of Molecular Genetics, Toxicology and Molecular Biology Branch, National Institute for Occupational Safety and Health, CDC, Morgantown, WV, USA

    B-Z Yuan, J Chapman & S H Reynolds

Authors
  1. B-Z Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S H Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B-Z Yuan.

Additional information

Disclaimer

The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention.

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuan, BZ., Chapman, J. & Reynolds, S. Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage. Oncogene 28, 3775–3786 (2009). https://doi.org/10.1038/onc.2009.240

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.240

Keywords

This article is cited by

Search

Advanced search

Quick links